LEXARIA BIOSCIENCE CORP. Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate
LEXARIA BIOSCIENCE CORP. (LEXX) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate of 0.00% for the 12-month period ending 2018-08-31, per its 10-K filed 2018-11-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate · last filed 2018-11-14
- LEXARIA BIOSCIENCE CORP. share-based goods and nonemployee services transaction, valuation method, expected dividend rate for the quarter ending 2017-11-30 was 0.00%.
- LEXARIA BIOSCIENCE CORP. share-based goods and nonemployee services transaction, valuation method, expected dividend rate for fiscal 2018 was 0.00%.
- LEXARIA BIOSCIENCE CORP. share-based goods and nonemployee services transaction, valuation method, expected dividend rate for fiscal 2017 was 0.00%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 3 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 6 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 9 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2018-08-31 | 0.00% 10-K · filed 2018-11-14 | |||
| 2018-05-31 | 0.00% 10-Q · filed 2018-07-13 | |||
| 2018-02-28 | 0.00% 10-Q · filed 2018-04-12 | |||
| 2017-11-30 | 0.00% 10-Q · filed 2018-01-12 | |||
| 2017-08-31 | 0.00% 10-K · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |